{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T16:46:56Z","timestamp":1745426816127},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,11,3]]},"DOI":"10.7759\/cureus.11310","type":"journal-article","created":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T16:53:41Z","timestamp":1604422421000},"source":"Crossref","is-referenced-by-count":5,"title":["Coronavirus-Associated Coagulopathy: Lessons From SARS-CoV1 and MERS-CoV for the Current SARS-CoV2 Pandemic"],"prefix":"10.7759","author":[{"given":"Shalinder","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ufara","family":"Zuwasti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Haas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"COVID-19 Map [Internet]. Johns Hopkins Coronavirus Resource Center. Accessed. [cited 2020 Jun 21]. Available from: https:\/\/coronavirus.jhu.edu\/map.html."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa254","article-title":"Acute pulmonary embolism and COVID-19 pneumonia: a random association?","volume":"41","author":"Danzi GB","year":"2020","unstructured":"Danzi GB, Loffi M, Galeazzi G, Gherbesi E. Acute pulmonary embolism and COVID-19 pneumonia: a random association?. Eur Heart J. 2020, 41:1858. 10.1093\/eurheartj\/ehaa254","journal-title":"Eur Heart J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-017-3144-z","article-title":"Epidemiology and clinical characteristics of human coronaviruses OC43, 229E, NL63, and HKU1: a study of hospitalized children with acute respiratory tract infection in Guangzhou, China","volume":"37","author":"Zeng Z-Q","year":"2018","unstructured":"Zeng Z-Q, Chen D-H, Tan W-P, Qiu S-Y, Xu D, Liang H-X. Epidemiology and clinical characteristics of human coronaviruses OC43, 229E, NL63, and HKU1: a study of hospitalized children with acute respiratory tract infection in Guangzhou, China. Eur J Clin Microbiol Infect Dis. 2018, 37:363-369. 10.1007\/s10096-017-3144-z","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2020.04.009","article-title":"Phylogenetic analysis and structural modeling of SARS-CoV-2 spike protein reveals an evolutionary distinct and proteolytically sensitive activation loop","volume":"432","author":"Jaimes JA","year":"2020","unstructured":"Jaimes JA, Andr\u00e9 NM, Chappie JS, Millet JK, Whittaker GR. Phylogenetic analysis and structural modeling of SARS-CoV-2 spike protein reveals an evolutionary distinct and proteolytically sensitive activation loop. J Mol Biol. 2020, 432:3309-3325. 10.1016\/j.jmb.2020.04.009","journal-title":"J Mol Biol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-0311-8","article-title":"The trinity of COVID- 19: immunity, inflammation and intervention","volume":"20","author":"Tay MZ","year":"2020","unstructured":"Tay MZ, Poh CM, R\u00e9nia L, MacAry PA, Ng LFP. The trinity of COVID- 19: immunity, inflammation and intervention. Nat Rev Immunol. 2020, 20:363-374. 10.1038\/s41577-020-0311-8","journal-title":"Nat Rev Immunol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2020.04.013","article-title":"Incidence of thrombotic complications in critically ill ICU patients with COVID-19","volume":"191","author":"Klok FA","year":"2020","unstructured":"Klok FA, Kruip MJHA, van der Meer NJM, Arbous MS, Gommers D a. MPJ, Kant KM. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020, 191:145-147. 10.1016\/j.thromres.2020.04.013","journal-title":"Thromb Res"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"28","author":"Zhou F","year":"2020","unstructured":"Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020, 28:1054-1062. 10.1016\/S0140-6736(20)30566-3","journal-title":"Lancet"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-020-02105-8","article-title":"Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2","author":"Yin S","year":"2020","unstructured":"Yin S, Huang M, Li D, Tang N. Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2. J Thromb Thrombolysis. 2020, 10.1007\/s11239-020-02105-8","journal-title":"J Thromb Thrombolysis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.16749","article-title":"COVID19 coagulopathy in Caucasian patients","volume":"189","author":"Fogarty H","year":"2020","unstructured":"Fogarty H, Townsend L, Ni Cheallaigh C, et al.. COVID19 coagulopathy in Caucasian patients. Br J Haematol. 2020, 189:1044-1049. 10.1111\/bjh.16749","journal-title":"Br J Haematol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2007575","article-title":"Coagulopathy and antiphospholipid antibodies in patients with COVID-19","volume":"382","author":"Zhang Y","year":"2020","unstructured":"Zhang Y, Xiao M, Zhang S, Xia P, Cao W, Jiang W. Coagulopathy and antiphospholipid antibodies in patients with COVID-19. N Engl J Med. 2020, 382:e38. 10.1056\/NEJMc2007575","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2020.03.037","article-title":"The pathogenesis and treatment of the `Cytokine Storm\u2019 in COVID-19","volume":"80","author":"Ye Q","year":"2020","unstructured":"Ye Q, Wang B, Mao J. The pathogenesis and treatment of the `Cytokine Storm\u2019 in COVID-19. J Infect. 2020, 80:607-613. 10.1016\/j.jinf.2020.03.037","journal-title":"J Infect"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2009.11.019","article-title":"Annexin A2 on lung epithelial cell surface is recognized by severe acute respiratory syndrome-associated coronavirus spike domain 2 antibodies","volume":"47","author":"Fang Y-T","year":"2010","unstructured":"Fang Y-T, Lin C-F, Liao P-C, Kuo Y-M, Wang S, Yeh T-M. Annexin A2 on lung epithelial cell surface is recognized by severe acute respiratory syndrome-associated coronavirus spike domain 2 antibodies. Mol Immunol. 2010, 47:1000-1009. 10.1016\/j.molimm.2009.11.019","journal-title":"Mol Immunol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2012.04.033","article-title":"D-dimer is a significant prognostic factor in patients with suspected infection and sepsis","volume":"30","author":"Rodelo JR","year":"2012","unstructured":"Rodelo JR, De la Rosa G, Valencia ML, Ospina S, Arango CM, G\u00f3mez CI. D-dimer is a significant prognostic factor in patients with suspected infection and sepsis. Am J Emerg Med. 2012, 30:1991-1999. 10.1016\/j.ajem.2012.04.033","journal-title":"Am J Emerg Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/jth.14817","article-title":"Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy","volume":"18","author":"Tang N","year":"2020","unstructured":"Tang N, Bai H, Chen X, Gong J, Li D, Sun Z. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost. 2020, 18:1094-1099. 10.1111\/jth.14817","journal-title":"J Thromb Haemost"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2011.04443.x","article-title":"Racial differences in venous thromboembolism","volume":"9","author":"Zakai NA","year":"2011","unstructured":"Zakai NA, McClure LA. Racial differences in venous thromboembolism. J Thromb Haemost. 2011, 9:1877-1882. 10.1111\/j.1538-7836.2011.04443.x","journal-title":"J Thromb Haemost"},{"key":"ref16","unstructured":"COVID- 19. Anticoagulation Recommended Even After Discharge [Internet]. (2020). Accessed: [cited 2020 Jun 23]. Available from: https:\/\/www.medpagetoday.com\/infectiousdisease\/covid19\/86230."},{"key":"ref17","unstructured":"Anticoagulation Guidance Emerging for Severe COVID-19 [Internet]. (2020). Accessed. [cited 2020 Jun 23]. Available from: https:\/\/www.medpagetoday.com\/infectiousdisease\/covid19\/85865."},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.04.031","article-title":"COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up: JACC state-of-the-art review","volume":"16","author":"Bikdeli B","year":"2020","unstructured":"Bikdeli B, Madhavan MV, Jimenez D, Chuich T, Dreyfus I. COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up: JACC state-of-the-art review. J Am Coll Cardiol. 2020, 16:2950-2973. 10.1016\/j.jacc.2020.04.031","journal-title":"J Am Coll Cardiol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/jth.14578","article-title":"Diagnosis and management of sepsis-induced coagulopathy and disseminated intravascular coagulation","volume":"17","author":"Iba T","year":"2019","unstructured":"Iba T, Levy JH, Warkentin TE, Thachil J, Poll T van der, Levi M. Diagnosis and management of sepsis-induced coagulopathy and disseminated intravascular coagulation. J Thromb Haemost. 2019, 17:1989-1994. 10.1111\/jth.14578","journal-title":"J Thromb Haemost"},{"key":"ref20","unstructured":"The potential of low molecular weight heparin to mitigate cytokine storm in severe COVID-19 patients. a retrospective clinical study | medRxiv [Internet]. . Accessed: [cited 2020 Jun 23]. Available from: https:\/\/www.medrxiv.org\/content\/10.1101\/2020.03.28.20046144v3."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/40246-coronavirus-associated-coagulopathy-lessons-from-sars-cov1-and-mers-cov-for-the-current-sars-cov2-pandemic","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:29:05Z","timestamp":1707506945000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/40246-coronavirus-associated-coagulopathy-lessons-from-sars-cov1-and-mers-cov-for-the-current-sars-cov2-pandemic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,3]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.11310","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11,3]]}}}